Lecanemab: Promising Cure or Expensive Gamble?
The debate over lecanemab, one of the first Alzheimer’s drugs to slow cognitive decline, is heating up.
Recent Posts
- WeCanReason Speakers’ Weekly Update
- Acknowledging the pandemic’s impact
- See what leaders in science, secularism, critical thinking, and skepticism did last week
- Drug delivery: revolutions in medicine
- Measuring Earth, Shaping Science
- Chicago Skepticamp 2026: A Day for Curious Minds and Critical Thinkers
- Planets near black holes explored
- ISS Leak Update: Normal Ops Resume
Social Media Auto Publish Powered By : XYZScripts.com